Elizabeth Nielson, Ph.D.
Co-Founder & Chief Executive Officer, Fluence
Professional Overview
Elizabeth Nielson, Ph.D., is a seasoned clinical psychologist and entrepreneur leading the charge in the field of psychedelic-assisted therapy. As the Co-Founder and Chief Executive Officer of Fluence, a pioneering company in the psychedelic medicine space, Dr. Nielson leverages her extensive clinical expertise and visionary mindset to drive innovation and accelerate the integration of psychedelics into mainstream mental healthcare.
Experience Summary
Current Role
As the Co-Founder and Chief Executive Officer of Fluence, Dr. Nielson is responsible for spearheading the company's strategic direction, overseeing its operations, and fostering a collaborative culture that empowers its multidisciplinary team. Under her leadership, Fluence has established itself as a trailblazer in the development and deployment of safe, effective, and evidence-based psychedelic-assisted therapies, solidifying its position as a trusted partner for healthcare providers, researchers, and the broader psychedelic medicine community.
Career Progression
Prior to her role at Fluence, Dr. Nielson held esteemed positions in academia and the psychedelic research field. She served as an Assistant Professor of Clinical Medical Psychology (in Psychiatry) and Project Clinician at the Columbia University Department of Psychiatry and the New York State Psychiatric Institute, where she conducted groundbreaking research on the therapeutic applications of psychedelics. Additionally, she has held advisory roles with prominent organizations, such as the Psychedelic Medicine Association and Sansero Life Sciences Inc., further cementing her status as a thought leader in the industry.
Academic Background
Dr. Nielson holds a Ph.D. in Clinical Psychology from Adelphi University, where she specialized in substance abuse and addiction treatment. Her academic achievements include postdoctoral fellowships at NYU Rory Meyers College of Nursing and the National Development & Research Institutes, Behavioral Science Training in Drug Abuse Research.
Areas of Expertise
- Psychedelic-assisted therapy
- Clinical research and trial design
- Substance abuse and addiction treatment
- Translational neuroscience and pharmacology
- Team building and organizational leadership
Professional Impact
Under Dr. Nielson's guidance, Fluence has emerged as a leader in the psychedelic medicine industry, driving groundbreaking research and developing innovative therapeutic protocols. The company's work has been recognized for its potential to revolutionize mental healthcare, attracting significant investments and garnering the attention of industry stakeholders and the broader public.
Conclusion
With her exceptional clinical expertise, entrepreneurial acumen, and unwavering commitment to advancing the field of psychedelic medicine, Dr. Elizabeth Nielson is poised to continue shaping the future of mental healthcare. As the Co-Founder and Chief Executive Officer of Fluence, she is dedicated to expanding access to safe and effective psychedelic-assisted therapies, ultimately improving the lives of individuals struggling with various mental health challenges.
